New diabetes clinical trial: EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial

Published on: May 01, 2019 at 07:00PM
Conditions:   Dyslipidemia Associated With Type II Diabetes Mellitus;   Diabetes Mellitus, Type 2;   Hypertension Arterial
Intervention:   Drug: Standard of Care + Evolocumab 140 MG/ML
Sponsor:   University of Campinas, Brazil
Recruiting